Drug Profile
Leukocyte cell therapy - Leap Therapeutics
Alternative Names: CureXcellLatest Information Update: 27 Jan 2017
Price :
$50
*
At a glance
- Originator MacroCure
- Developer Leap Therapeutics
- Class Cell therapies
- Mechanism of Action Cell replacements; Growth substance stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic foot ulcer; Leg ulcer